ITADCs to emerge as one-stop growth hubs for Textile Entrepreneurs: Giriraj Singh (See 'Corp Brief') NMCG's focus on Nature Based Solutions: Initiation of two pilot projects and training programs on NbS (See 'Corp Brief') IPR - For purposes of Sec 57 of Trade Marks Act, foreign proprietor may succeed in rectification by proving that its mark had acquired actionable recognition, even without formal commercial launch or direct sales: HC (See 'Legal Desk') Insurance Division, DFS, secures 2nd Rank in Group A Category Grievance Redressal Assessment (See 'Corp Brief') Standing Committee of National Board for Wildlife reviews progress on Key Conservation Initiatives (See 'Corp Brief') BharatNet-enabled integrated phygital service delivery model secures global honour (See 'Corp Brief') IBC - Demand notice in Form B under Rule 7(1) of Personal Guarantor Rules is only procedural requirement prior to filing and does not amount to invocation of guarantee: NCLT (See 'Legal Desk') Shivraj Singh Chouhan, Taliban minister discuss agricultural ties (See 'Corp Brief') Union Ministry Launches Integrated Training for Primary Healthcare Teams (See 'Corp Brief') Advancing Women's Leadership at Grassroots, held as part of BRICS Women Ministerial Meeting in Kochi (See 'Corp Brief') SARFAESI - Borrowers who fail to timely invoke MSME framework are precluded from seeking its protection at belated stage after SARFAESI proceedings have commenced: HC (See 'Legal Desk') Bhubaneswar Declaration charts roadmap to transform Tribal Research Institutes into centres of excellence (See 'Corp Brief') TEC signs MoU with BECIL to strengthen Telecom and Broadcasting Ecosystem (See 'Corp Brief') NLDSL and Punjab sign MoU to strengthen Digital Logistics Ecosystem (See 'Corp Brief') Competition Act - OP entered into anti-competitive agreements & abused its dominant position by imposing unfair & restrictive conditions on participants in its beauty pageant, in contravention of Sections 3 & 4 - D-G to probe matter: CCI (See 'Legal Desk') Kamarajar Port becomes India's Second Major Port with 18-Metre Draft Capability (See 'Corp Brief') Large-Scale Infrastructure Expansion opens up Opportunities for Budding Engineers (See 'Corp Brief') CCI okays merger of 51 Malabar Group's companies into Malabar Gold and Diamonds Ltd (See 'Corp Brief') IBC - Delayed creation of security cannot be treated as transaction in normal course of business: NCLAT (See 'Legal Desk') CCI approves acquisition of equity in Sorting Hat Technologies and merger into upGrad Education (See 'Corp Brief') Atal Innovation Mission Strengthens Eastern India Innovation Ecosystem (See 'Corp Brief') Giriraj Singh to inaugurate 'Indie Haat 2026' (See 'Corp Brief') IBC - Rent Tribunal lacks jurisdiction in cases involving entities undergoing CIRP, per Sections 60(5)(c) & 238 of IBC, which confer exclusive jurisdiction upon the Adjudicating Authority in CIRP matters: NCLT (See 'Legal Desk') Labour Ministry translates objectives of Labour Codes to provide timely relief to workers (See 'Corp Brief') Trade Marks - Mark KREOFLAT is distinctively similar to existing mark of PANKREOFLAT where former copies essential & distinctive features of latter, thereby making the former visually, phonetically & deceptively similar: HC (See 'Legal Desk') CAQM reports 62 air pollution violations across NCR in 17 days; proposes closure of four units (See 'Corp Brief') Utsav & Chintan Shivir 2026 to focus on institutional reforms for a technology-driven, and citizen-centric legal ecosystem (See 'Corp Brief') Sukesh Chandrashekhar con saga - co-accused gets bail - stringent conditions of Section 45 of PMLA can be relaxed for women, more so considering extraordinary circumstances: HC (See 'Legal Desk') Govt raises onion procurement price by 13% to Rs.2,125 per quintal (See 'Corp Brief') India's last 12 years have been a progression from shortages to building Viksit Bharat: RM (See 'Corp Brief') SARFAESI - Writ jurisdiction under Article 226 should ordinarily not be exercised where efficacious alternative remedy exists, particularly in matters arising under the SARFAESI Act: HC (See 'Legal Desk') India's youth will power AI, robotics with Made in India chips: PM (See 'Corp Brief') Competition Act - Allegations relating to use of private vehicles without commercial permits, non-compliance with Motor Vehicles Act, opaque GST & STA tax practices, & related issues fall outside scope of Competition Act: CCI (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT')

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES